Resmed (RSMDF) Revenue (2009 - 2026)

Resmed has reported Revenue for 18 years, with the latest figure at $1.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 10.81% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at $5.5 billion (up 10.28% YoY), and the FY2025 full-year result was $5.1 billion, up 9.84% from the prior year.
• Revenue for Q1 2026 stood at $1.4 billion, up from $1.4 billion in the prior quarter.
• The five-year high for Revenue was $1.4 billion in Q1 2026, with the low at $864.5 million in Q1 2022.
• Historically, Revenue has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
• Annual changes were most pronounced in 2022 — Revenue gained 4.41% — and 2023, when it rose 29.2%.
• Resmed's Revenue stood at $1.0 billion in 2022, then climbed by 12.48% to $1.2 billion in 2023, then grew by 10.26% to $1.3 billion in 2024, then grew by 10.98% to $1.4 billion in 2025, then rose by 0.6% to $1.4 billion in 2026.
• The last three Revenue figures came in at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.